Stock screener

AEON

Conviction 4HealthcareScan · Thu, Jun 25, 2026
Bullish marubozu
AEON$0.7147-1.42%
ResistanceSupportVol 14
63 bars
Vol MA14 32.88K
Mar 26Apr 14May 1May 19Jun 8Jun 25
AEON Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.aeonbiopharma.com
Price0.7147
Change-1.42%
Gap-3.45%
Rel volume0.38×
Avg volume30.6K
Avg $ vol21.61K
SMA 200.7099
SMA 500.8332
SMA 2000.9507
Price vs 50-14.22%
Price vs 200-24.82%
MA stackbearish
50/200 cross
Supertrenddown · 0.7687
RSI (14)45
MACD hist0.01
MACD crossbull · 5d
Stoch %K / %D86 / 84
ADX (14)33
+DI / −DI14 / 35
RSI divergence
MACD divergence
ATR %+7.47%
ADR %6.26%
52w high1.40
52w low0.6566
From 52w high-48.95%
Above 52w low+8.85%
New 52w highNo
SqueezeOn · 5d
Bollinger width16.57%
%B0.54
Donchian pos73.90%
Donchian high0.7870
Donchian low0.5100
AVWAP (52w high)0.9720
vs AVWAP high-26.47%
AVWAP (52w low)0.6574
vs AVWAP low+8.72%
OBV trendDown
Chaikin MF (20)-0.07
Today vs 20d0.38×
Avg vol (14d)32.88K
Avg vol (20d)30.6K
Avg $ vol (20d)21.61K
Market cap18.8M
RS 3m (vs SPY)-43.86%
RS 6m (vs SPY)-40.61%
RS line new highNo
Trend template1/8
Technical rank20.4
1 week+6.10%
1 month-7.18%
3 months-29.93%
6 months-31.28%
1 year+0.95%
YTD-35.61%
P/E-0.48
P/B-1.12
P/S
P/FCF-1.09
EPS-3.95
Div yield
ROE234.13%
ROA-454.48%
Debt/Eq
Current0.99
EV/EBITDA-0.99
Gross margin
Net margin
Rev growth
EPS growth-193.37%
Price target
Target upside
Analyst rating
Institutional
Ent. value12.56M
Revenue
Net income-11.79M
Gross profit
Free cash flow-17.31M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out26.31M
Employees8
ListedMon, Jul 24, 2023
Free float9.82M
Float %81.1%
Short interest219.22K
Days to cover3.0d
Short volume17.4%
Squeeze score20 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.44
Last surprise
Setup gradeD
Conviction4 / 100
Pattern quality
Tech rank20.4 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBullish marubozu
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AEON

All disclosures →
No recent disclosed trades by Congress in AEON. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AEON · 5 buys

InsiderSideShares
Carter Eric G
Director · Class A Common Stock · 2026-06-17
Grant222.68K
FISCHER JOST
Director · Class A Common Stock · 2026-06-17
Grant222.68K
Forth Marc
Director · Class A Common Stock · 2026-06-17
Grant222.68K
PALMISANO ROBERT J
Director · Class A Common Stock · 2026-06-17
Grant222.68K
Thunen Shelley B
Director · Class A Common Stock · 2026-06-17
Grant222.68K

SEC filings

EDGAR filings in AEON · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.